Navigation Links
S/5 Compact Critical Care Monitor

ProductsS/5 Compact Critical Care Monitor
Company Datex-Ohmeda, Inc.
Item S/5 Compact Critical Care Monitor
Features 
  • Ideally suited for medium care.
  • Integrates basic hemodynamic and all airway gas measurements.
  • A compact 2+2 slot monitor using standard S/5 Datex-Ohmeda modules.
  • Provides unique capabilities of patient spirometry, continuous gas exchange/metabolics, automated tonometry and neuromuscular transmission.
  • Large 12.1" color display.
  • User interface specifically designed for the critical care environment.
  • Uses standard Datex-Ohmeda monitoring accessories for added flexibility.
    • Description Flexible, modular, easy to use.

    The S/5 Compact Critical Care Monitor is a modular, small-footprint monitor ideally suited for medium care monitoring. The monitor uses standard S/5 measurement modules and Datex-Ohmeda supplies and accessories.

    The S/5 Compact Critical Care Monitor shares the same user interface and features as the S/5 Critical Care Monitor. Its large 12.1"active matrix color LCD display provides excellent visibility and viewing angles even at a distance.
    Info Datex-Ohmeda, Inc.
    Customer Service: (800) 345-2700
    Web site: http://www.us.datex-ohmeda.com/index.asp

    Related medicine products :

    1. Compact Ultrasonic Phacoemulsification System
    2. Oculus Easyfield Compact Perimeter
    3. Compact 30C CO2 Lasers
    4. Compact 40C CO2 Lasers
    5. Veris Compact
    6. Compact KTP laser
    7. Veris Compact™
    8. Adams Compact II
    9. GR 20.22 Compact High Speed Refrigerated Floor-Standing Centrifuge
    10. BR 4i Compact Multi-Function Refrigerated Bench-Top Centrifuge.
    11. CR 3i Compact Multi-Function Refrigerated Bench-Top Centrifuge.
    The Omni-Flex System provides the capability to change frame arms in the middle of surgery while retaining exposure with tension on the incision. The system is also strong enough to be stable for lar
    ...actor System represents the most widely accepted "...array of retraction components provides numerous s...lti-directional exposure of the surgical field. In...pecific procedures: IMA Kit / Bariatric Kit / Spin...
    ...he Alexis Wound Retractor provides circumferential...ination. For open surgery, the Alexis Retractor pr...ion size. For laparoscopic surgery, the Alexis Ret...protection when an organ or specimen requires remo...
    Pipetman Concept is a revolutionary motorized electronic pipette. Conceived with simplicity and flexibility in mind, Pipetman Concept features exclusive multifunction characteristics and a direct pip
    Medicine Products:
    (Date:10/7/2008)...uncement of planned bequest comes at stem cell sym...wswire/ -- Just over one year,ago, retail pioneer ...the,University of Michigan, to endow a new researc...reventing human disease., Today, at the institute...that he will bequeath an additional $22 million to...
    (Date:10/7/2008)...0,000 PEOPLE ACROSS THE NATION HAVE SAID ,I VOTE F...ALLAS, Oct. 7 /PRNewswire/ -- To aid and help educ... the positions of presidential candidates,Senators...nd cancer issues,the Susan G. Komen for the Cure(...sources available on its web site --, http://www.I...
    (Date:10/7/2008)... Wyndstorm Corporation ( www.wyndstorm.co...ia company, announced a key win with Muve, Inc. ( ...ing plan program design to promote Muve,s activity...ign project will ultimately help Muve,s corporate ...employees via interactive messaging, rewards progr...
    (Date:10/7/2008)... means better access, more choices for Indiana hea...FORT WAYNE, Ind., Oct. 7 /PRNewswire/ -- Lutheran ...ement to partner with Consumers Life Insurance,Com...ervice to consumers in,12 Indiana counties includi...ork partnership is Fort Wayne,s Lutheran,Hospital,...
    Breaking Medicine News(10 mins):Health News:Alfred Taubman Announces New $22M Gift to U-M 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 3Health News: 3D Social Media Application Aims to Cut Workplace Obesity : Muve, Inc., Selects Social Media Developer Wyndstorm Corporation to Design Online Promotions for Corporate Wellness Program 2Health News: 3D Social Media Application Aims to Cut Workplace Obesity : Muve, Inc., Selects Social Media Developer Wyndstorm Corporation to Design Online Promotions for Corporate Wellness Program 3Health News:Consumers Life Expands Healthcare Network in Northeast Indiana 2
    ...ers at the University of Michigan C.S. Mott Childr...are at an increased// risk for influenza-related c...e flu, even when they visit their doctor during fl... Archives of Pediatric and Adolescent Medicine, th...
    ...national team of researchers is developing a new g...between donors and recipients//. The Bloodchip giv...sts. The current tests look for blood types while ...es”. A spokeswoman for the National Blood Service...
    ...ican Physical Therapy Association (APTA) has said ... part of workplace injuries. It is a repetitive-st...of the popular BlackBerry devices. "The use of PD... longer limited to the eight hours spent in the wo...
    ...ionel Richie was so fearful over his daughter Nico...r to the doctors personally and find out the probl...cared for his daughter's health and wanted to know...der. He says: "Believe me, I've checked it out t...
    Other Medicine News:Health News:Few Medicaid Kids with Asthma Get Recommended Flu Shot 2Health News:Few Medicaid Kids with Asthma Get Recommended Flu Shot 3Health News:Novel genetic blood test 2
    (Date:10/6/2008)...rate to Improve Patient Safety, WASHINGTON, Oct. ...of,Cardiology in collaboration with the American C...Association today released consensus guidelines,ou...of ulcers and,gastrointestinal (GI) bleeding among...gs (NSAIDs) along with antiplatelet agents., Gast...
    (Date:10/6/2008)... Therapy is More Likely to Induce Steroid-Free R...d Immunomodulator, Azathioprin...sented for the first time,from the Phase 3b Study ...dulators and Biologic Therapy (SONIC) may provide ... with moderate to severe Crohn,s disease.,Accordin...
    (Date:10/6/2008)...severe patients achieved endoscopic,response and m...at Week 10,in data from a 54-week open-label study...logy (ACG) Annual Scientific Meeting, ORLANDO, Fl...a from a,large, prospective study investigating en...a biologic compound. The data presented at the Ame...
    (Date:10/6/2008)... Weeks of Radiation Therapy -, Event: Watch Single...day, October 22, 2008, 3 - 4 p.m. by visiting ...a., Oct. 6 / Questions raced through ...t cancer in May. Would she have the,tumor removed ...therapy?, , To view the Multimedia News Release,...
    Breaking Medicine Technology:Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Aberrations in region of chromosome 1q21 1 associated with broad range of disorders in children 4819 1Aberrations in region of chromosome 1q21 1 associated with broad range of disorders in children 4819 2Aberrations in region of chromosome 1q21 1 associated with broad range of disorders in children 4819 3How do race genetics and health care disparities affect spread of HIV 3F 4816 1Eatn Park to Thank Guests for Their Support of the Chains Decision to Go Smoke Free 26272 19 11s Health Effects Lingered for Years 26268 19 11s Health Effects Lingered for Years 26268 29 11s Health Effects Lingered for Years 26268 3
    ...(BUSINESS WIRE)--May 25, 2007 - ARIAD,Pharmaceutic...ical,investigators from leading cancer centers wil...g trials of the Company,s novel mTOR,inhibitor, AP...ty,of Clinical Oncology (ASCO) in Chicago, Illinoi...he Phase 2 trial of single-agent,AP23573 in patien...
    ...(BUSINESS WIRE)--May 24, 2007 - A new analysis,has...igned in ways,that inadvertently omit women and Af...niversity School of Medicine,researcher who led th...tists that strict study eligibility criteria can h...ng data from a pool of 100,000 alcohol treatment,p...
    Other Medicine Technology:Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 2Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 3Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 4Limiting Eligibility for Medical Studies Can Omit Women,African-Americans, Stanford Study Finds 2Limiting Eligibility for Medical Studies Can Omit Women,African-Americans, Stanford Study Finds 3